GGrantIndex
← Leaderboards

Richard M Novak

Rush University Medical Center

$18,214,129
Attributed
$27,601,324
Total exposure
7
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.2M · FY200723
$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$25,827,226 · 5
CDC$1,774,098 · 1
AHRQ$0 · 1

By mechanism

UL1$18,774,390 · 1
U01$5,263,746 · 2
P01$1,891,676 · 2
UM1$1,671,512 · 1
R18$0 · 1

Top collaborators

Most similar at Rush University Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Programs

Research focus

ProgramsUniversitiesChicagoIllinoisFundingSamplingWomanPrincipal InvestigatorCollaborationsMucosal ImmunityClinical ResearchLeadershipMicrobicideAfrican AmericanIncidenceMedical CenterPeripheral Blood Mononuclear CellLaboratoriesHiv VaccineClinicHospitalsClinical SciencesAreaClinical Trials

Grant awards (27)

Clinical and Translational Science Award$3,710,433
UL1 · FY2023 · TR
Clinical and Translational Science Award$3,709,249
UL1 · FY2022 · TR
Clinical and Translational Science Award$3,575,489
UL1 · FY2021 · TR
Quality Assurance and Quality Control Administrative Supplement$199,143
UL1 · FY2021 · TR
Strengthening Stakeholder Engagement in Human Research Protections.$159,900
UL1 · FY2021 · TR
Clinical and Translational Science Award$3,769,999
UL1 · FY2020 · TR
Clinical and Translational Science Award$3,650,177
UL1 · FY2019 · TR
Syphilis in Chicago: Epidemiology, Sexual Networking and Modeling for Prevention$591,366
U01 · FY2019 · PS · contact PI
Syphilis in Chicago: Epidemiology, Sexual Networking and Modeling for Prevention$591,366
U01 · FY2018 · PS · contact PI
Syphilis in Chicago: Epidemiology, Sexual Networking and Modeling for Prevention$591,366
U01 · FY2017 · PS · contact PI
Targeting High-Risk Women for HVTN and Microbicide Trials$585,496
UM1 · FY2014 · AI · contact PI
Targeting High-Risk Women for HVTN and Microbicide Trials$491,748
UM1 · FY2013 · AI · contact PI
HIV Specific Immunity in Highly Exposed Uninfected Women$319,306
P01 · FY2013 · AI · contact PI
Targeting High-Risk Women for HVTN and Microbicide Trials$594,268
UM1 · FY2012 · AI · contact PI
HIV Specific Immunity in Highly Exposed Uninfected Women$340,497
P01 · FY2012 · AI · contact PI
Targeting High-Risk Women for HVTN and Microbicide Trials$582,711
U01 · FY2011 · AI · contact PI
HIV Specific Immunity in Highly Exposed Uninfected Women$334,890
P01 · FY2011 · AI · contact PI
Targeting High-Risk Women for HVTN and Microbicide Trials$588,324
U01 · FY2010 · AI · contact PI
HIV Specific Immunity in Highly Exposed Uninfected Women$360,887
P01 · FY2010 · AI · contact PI
Targeting High-Risk Women for HVTN and Microbicide Trials$594,268
U01 · FY2009 · AI · contact PI
HIV Specific Immunity in Highly Exposed Uninfected Women$338,900
P01 · FY2009 · AI · contact PI
Targeting High-Risk Women for HVTN and Microbicide Trials$596,555
U01 · FY2008 · AI · contact PI
Targeting High-Risk Women for HVTN and Microbicide Trials$1,127,790
U01 · FY2007 · AI · contact PI
Female genital tract immunity and HIV vaccine responses$197,196
P01 · FY2002 · HD
HIV Treatment Error Reduction Using a Genotype Database$0
R18 · FY2002 · HS
HIV Treatment Error Reduction Using a Genotype Database$0
R18 · FY2001 · HS
Female genital tract immunity and HIV vaccine responses$0
P01 · FY2001 · HD